Infertility Treatment Not Linked to Children's Development

This article originally appeared here.
Share this content:
Infertility Treatment Not Linked to Children's Development
Infertility Treatment Not Linked to Children's Development

TUESDAY, Jan. 5, 2016 (HealthDay News) -- Infertility treatment seems not to be associated with children's development through age 3 years, according to a study published online Jan. 4 in JAMA Pediatrics.

Edwina H. Yeung, Ph.D., from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Md., and colleagues conducted a prospective cohort study based on infertility treatment and plurality. A total of 4,824 mothers completed one or more developmental screening instruments for children, including 1,830 conceived with infertility treatment (categorized into assisted reproductive technology [ART] and ovulation induction/intrauterine insemination). Parents completed the Ages and Stages Questionnaire to assess five developmental domains through 36 months of age.

The researchers identified 1,422 mothers who underwent infertility treatment. There was no correlation for infertility treatment with the risk of child failure in any developmental domain (adjusted odds ratio [aOR], 1.33; 95 percent confidence interval [CI], 0.94 to 1.89). When singletons and twins were assessed together, ART correlated with increased risk for failing any developmental domain (aOR, 1.81; 95 percent CI, 1.21 to 2.72). This estimate was further attenuated after adjustment for birth weight (aOR, 1.26; 95 percent CI, 0.82 to 1.93). There was no significant association for type of treatment with failing any domain after stratifying by plurality.

"After considering plurality, children's development through age 3 years was similar irrespective of infertility treatment or specific type," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »